来源：FM93交通之声 家长最担心的离谱事件发生了 近日，湖北武汉的杨女士向媒体透露 自家女儿眼镜镜片被店员不小心配反 原本4年的远视储备孩子1年就消耗完了 杨女士称，去年二月份她带着7岁女儿去眼科医院检查视力，因散光度数有增长需更换眼镜，于是杨女 士拿着医院的验光单去眼镜店配镜，不料十个月后，孩子的视力状况反而愈发严重。 杨女士告诉记者："2025年12月28日，我带孩子去门店让店员测了一下，他就说我们家孩子有近视，我 说不对呀，孩子怎么会有近视，她只有散光，每年都会监测。"随后杨女士带孩子前往医院检测，医生 的话让杨女士大吃一惊："他说我的镜片配反了，我孩子是远视储备175度加散光200度，他配成了近视 175度跟近视200度，医生说这个属于员工配错的，导致孩子眼轴快速增长，本来是4年的远视储备孩子1 年就消耗完了。" 随后，医生建议杨女士给孩子配离焦眼镜，控制、延缓孩子的近视。 记者咨询涉事公司区域经理，询问为何当初镜片会配错，该经理回应：目前具体情况公司内部也正在调 查，将会给杨女士一个答复。 杨女士告诉记者，经协商后，眼镜店愿意赔付2万元，双方达成一致。 随着电子产品在孩子的生活与学习中普及，为自家 ...

Group 1 - The core viewpoint emphasizes the importance of controlling the progression of myopia in children rather than attempting to reverse it, as most optical methods can only slow down the increase in myopia [2][3] - For children around the age of 10 with myopia under 100 degrees, optical methods like functional frame glasses and OK lenses may show some cases of myopia regression, but this is not common [2] - It is crucial to conduct cycloplegic refraction tests to accurately assess myopia, as traditional vision tests may not detect low degrees of myopia in children who still have normal visual acuity [3] Group 2 - For children who have already developed myopia, intervention measures should be tailored based on the degree of myopia and astigmatism, as well as the individual child's situation [3] - Functional frame glasses or OK lenses are recommended for children with relatively low myopia and high astigmatism, but adjustments should be made based on the child's response and axial growth [3] - Children with low myopia or pure astigmatism may be better suited to wear frame glasses [3]

Core Viewpoint - The company reported strong revenue growth in 2024, but faced a decline in net profit in Q1 2025 due to market pressures from centralized procurement and reduced surgical volumes [1][2]. Financial Performance - In 2024, the company achieved revenue of 1.41 billion yuan, a year-on-year increase of 48.24%, and a net profit of 388 million yuan, up 27.77% [1]. - For Q1 2025, revenue was 357 million yuan, reflecting a year-on-year growth of 15.07%, while net profit decreased to 93 million yuan, down 10.05% [1]. Product Performance - Revenue from artificial crystalline lenses reached 588 million yuan in 2024, growing by 17.66%, with sales volume increasing by 44.93% [2]. - The company’s revenue from myopia control products grew by 20.79%, driven by the introduction of various new products [2]. R&D Investment and New Business Growth - The company increased R&D investment to 160 million yuan in 2024, a rise of 20.80%, representing 11.33% of total revenue [3]. - The contact lens business saw significant growth, with revenue reaching 426 million yuan, a staggering increase of 211.84% [3]. Market Outlook - The company is projected to achieve revenues of 1.81 billion yuan, 2.26 billion yuan, and 2.79 billion yuan for 2025-2027, with respective growth rates of 28.44%, 24.91%, and 23.12% [4]. - Expected net profits for the same period are 467 million yuan, 600 million yuan, and 778 million yuan, with growth rates of 20.21%, 28.55%, and 29.63% [4]. Earnings Per Share - The projected EPS for the years 2025, 2026, and 2027 are 2.46 yuan, 3.17 yuan, and 4.10 yuan respectively [5].